These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 27175740)

  • 21. One-year adherence to warfarin treatment for venous thromboembolism in high-risk patients and its association with long-term risk of recurrent events.
    Chen SY; Wu N; Gulseth M; LaMori J; Bookhart BK; Boulanger L; Fields L; Schein J
    J Manag Care Pharm; 2013 May; 19(4):291-301. PubMed ID: 23627575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Initial choice of oral glucose-lowering medication for diabetes mellitus: a patient-centered comparative effectiveness study.
    Berkowitz SA; Krumme AA; Avorn J; Brennan T; Matlin OS; Spettell CM; Pezalla EJ; Brill G; Shrank WH; Choudhry NK
    JAMA Intern Med; 2014 Dec; 174(12):1955-62. PubMed ID: 25347323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacogenetics of hypoglycemia associated with sulfonylurea therapy in usual clinical care.
    Mitchell SL; Leon DAC; Chaugai S; Kawai VK; Levinson RT; Wei WQ; Stein CM
    Pharmacogenomics J; 2020 Dec; 20(6):831-839. PubMed ID: 32504053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Initial therapy, persistence and regimen change in a cohort of newly treated type 2 diabetes patients.
    Grimes RT; Bennett K; Tilson L; Usher C; Smith SM; Henman MC
    Br J Clin Pharmacol; 2015 Jun; 79(6):1000-9. PubMed ID: 25521800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characteristics Relating to Adherence and Persistence to Basal Insulin Regimens Among Elderly Insulin-Naïve Patients with Type 2 Diabetes: Pre-Filled Pens versus Vials/Syringes.
    Slabaugh SL; Bouchard JR; Li Y; Baltz JC; Meah YA; Moretz DC
    Adv Ther; 2015 Dec; 32(12):1206-21. PubMed ID: 26563324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of dual-therapy intensification with insulin or dipeptidylpeptidase-4 inhibitor on cardiovascular events and all-cause mortality in patients with type 2 diabetes: A retrospective cohort study.
    Jil M; Rajnikant M; Richard D; Iskandar I
    Diab Vasc Dis Res; 2017 Jul; 14(4):295-303. PubMed ID: 28330386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sulfonylurea monotherapy and emergency room utilization among elderly patients with type 2 diabetes.
    Rajpathak SN; Fu C; Brodovicz K; Engel SS; Heaton PC
    Diabetes Res Clin Pract; 2015 Sep; 109(3):507-12. PubMed ID: 26123984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of all-cause mortality with pioglitazone and insulin in type 2 diabetes: an expanded analysis from a retrospective cohort study.
    Yang J; Vallarino C; Bron M; Perez A; Liang H; Joseph G; Yu S
    Curr Med Res Opin; 2014 Nov; 30(11):2223-31. PubMed ID: 24983744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypoglycemia in patients with type 2 diabetes newly initiated on basal insulin in the US in a community setting: impact on treatment discontinuation and hospitalization.
    Dalal MR; Kazemi MR; Ye F
    Curr Med Res Opin; 2017 Feb; 33(2):209-214. PubMed ID: 27737571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance.
    Hertz RP; Unger AN; Lustik MB
    Clin Ther; 2005 Jul; 27(7):1064-73. PubMed ID: 16154485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Healthcare resource use and associated costs of hypoglycemia in patients with type 2 diabetes prescribed sulfonylureas.
    Alemayehu B; Liu J; Rajpathak S; Engel SS
    J Diabetes Complications; 2017 Nov; 31(11):1620-1623. PubMed ID: 28844830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct medical costs of severe hypoglycaemic events in patients with type 2 diabetes in England: A retrospective database study.
    Holbrook T; Tang Y; Das R; Shankar RR; Tunceli K; Williams J; Radican L; Holden SE; Morgan CL; Piercy J; Currie CJ
    Int J Clin Pract; 2017 Jun; 71(6):. PubMed ID: 28544081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of sulfonylurea agents in older diabetic patients.
    Peters AL; Davidson MB
    Clin Geriatr Med; 1990 Nov; 6(4):903-21. PubMed ID: 2224754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sulfonylurea use and risk of hip fractures among elderly men and women with type 2 diabetes.
    Rajpathak SN; Fu C; Brodovicz KG; Engel SS; Lapane K
    Drugs Aging; 2015 Apr; 32(4):321-7. PubMed ID: 25825122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The risk of overall mortality in patients with Type 2 diabetes receiving different combinations of sulfonylureas and metformin: a retrospective analysis.
    Pantalone KM; Kattan MW; Yu C; Wells BJ; Arrigain S; Nutter B; Jain A; Atreja A; Zimmerman RS
    Diabet Med; 2012 Aug; 29(8):1029-35. PubMed ID: 22248043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Order of discontinuation of glucose-lowering medications following bariatric surgery.
    Vouri SM; Chen J; Sparkman J; Salles A; Micek ST
    Diabetes Res Clin Pract; 2021 Feb; 172():108580. PubMed ID: 33316313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between antihypertensive drug use and hypoglycemia: a case-control study of diabetic users of insulin or sulfonylureas.
    Thamer M; Ray NF; Taylor T
    Clin Ther; 1999 Aug; 21(8):1387-400. PubMed ID: 10485510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypoglycaemia seriousness and weight gain as determinants of cardiovascular disease outcomes among sulfonylurea users.
    Nunes AP; Iglay K; Radican L; Engel SS; Yang J; Doherty MC; Dore DD
    Diabetes Obes Metab; 2017 Oct; 19(10):1425-1435. PubMed ID: 28497592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment modification after initiating second-line medication for type 2 diabetes.
    Liss DT; Cherupally M; O'Brien MJ; Kang RH; Aikman C; Wallia A; Cooper AJ; Koep E; Parker ED; Ackermann RT
    Am J Manag Care; 2023 Dec; 29(12):661-668. PubMed ID: 38170483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Compliance and persistence with concomitant statin and oral antihyperglycemic therapy.
    Zhang Q; Zhao C; Davies MJ; Radican L; Seck T
    Am J Manag Care; 2011 Nov; 17(11):746-52. PubMed ID: 22084894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.